Copyright
©The Author(s) 2018.
World J Clin Cases. Nov 26, 2018; 6(14): 854-861
Published online Nov 26, 2018. doi: 10.12998/wjcc.v6.i14.854
Published online Nov 26, 2018. doi: 10.12998/wjcc.v6.i14.854
Figure 6 The contrast in the presentation of pretibial myxedema before and after glucocorticoid therapy.
A: Pretibial myxedema at baseline; B: Four months after the initiation of local glucocorticoid treatment; C: Seven months after the end of treatment. Compared with baseline (A), pretibial myxedema remitted completely 4 mo after the initiation of local glucocorticoid treatment (B). Seven months after the end of treatment, no recurrence of pretibial myxedema was observed (C).
- Citation: Zhang F, Lin XY, Chen J, Peng SQ, Shan ZY, Teng WP, Yu XH. Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature. World J Clin Cases 2018; 6(14): 854-861
- URL: https://www.wjgnet.com/2307-8960/full/v6/i14/854.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i14.854